Here we identify the therapeutic effects of targeting ACLY in T-ALL in vivo:

https://www.biorxiv.org/content/10.1101/2023.03.27.534395v2

The Rally! Foundation through its Collaborative Pediatric Cancer Research Awards Program will fund a 2-year research grant to study Glutamine Synthetase as a therapeutic target in T-ALL! Thanks for your support!!

Collin is one of the 2023 awardees of the Alex’s Lemonade Stand Foundation (ALSF) Pediatric Oncology Student Training (POST) program. This is an exciting opportunity for Collin to keep getting hands on training on pediatric leukemia research, way to go!!

The Herranz lab collaborates with the Rabinowitz Lab (Princeton) to publish an article in Nature:

Slow TCA flux and ATP production in primary solid tumours but not metastases

https://www.nature.com/articles/s41586-022-05661-6

Thank you everyone for a really fun time! With best wishes for 2023!!

Vicky is one of the 2023 awardees of the TRTH program from ASH and EHA. This is an exciting opportunity for her, congrats Vicky!!

Welcome to the lab, Oekyung!

Dietary glucosamine overcomes the defects in αβ-T cell ontogeny caused by the loss of de novo hexosamine biosynthesis

https://www.nature.com/articles/s41467-022-35014-w

We are sad to see Hossein Khiabanian leave Rutgers, but we are excited to welcome some of his previous trainees in our own lab.
Amartya Singh (postdoc), Chris Thai (PhD candidate) and Byron Avihai (MDPhD candidate) will continue their studies in our lab, welcome to all of you!!

Very happy to share our identification of a novel NOTCH1-SIRT1-KAT7 axis in T-ALL!
Thanks to everyone involved in this story!!